What is Pirfenidone?

An example of Pirfenidone

Pirfenidone is an anti-fibrotic and antiinflammation medication used to slow the progression of idiopathic pulmonary fibrosis. It is currently approved in Europe, Asia and Canada, but not the United States.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
Perceived Effectiveness
Purpose # of patients # of patients with evaluations
Major
Moderate
Slight
None
Can’t tell
5 1 Efficacy_moderate

See all 4 patients currently taking Pirfenidone

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
1
Mild
0
None
0

Commonly reported side effects, conditions, and hospitalizations associated with Pirfenidone

1
1
1
1
1
Hospitalization 1
See all 6 reported side effects See top 6 reported side effects

Reported Dosages

  9 capsule(s) daily 9 other daily 20 mg daily 801 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Pirfenidone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 1   Other: 50%
Course of treatment ended 1   Course of treatment ended: 50%

See all 1 patient who’ve stopped taking Pirfenidone

Currently Taking Pirfenidone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Pirfenidone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Pirfenidone

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Pirfenidone

Very
0 0%
Somewhat
1 100%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

Cost of Pirfenidone

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

There are no evaluations for Pirfenidone .

1 additional evaluation for Pirfenidone is not currently shared publicly.

Last updated: